ArticleCancer medicine2024

Exploring the Potential of Enhanced Prognostic Performance of NCCN-IPI in Diffuse Large B-Cell Lymphoma by Integrating Tumor Microenvironment Markers: Stromal FOXC1 and Tumor pERK1/2 Expression.

Ji-Ye Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.